$NDRM Headlines Civeo shares plunge; NeuroDerm
Post# of 44845
Posted On: 01/07/2015 10:16:50 AM
$NDRM Headlines
Civeo shares plunge; NeuroDerm jumps 11:51 a.m. Dec. 30, 2014 - Wallace Witkowski
NeuroDerm shares surge 19.6% as Parkinson's treatment shows promise 7:57 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm shares surge 18% in premarket trade 7:46 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm reports positive results in trial of Parkinson's treatment 7:45 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm Ltd. (NDRM) in Focus: Stock Surges 13.2% - Tale of the Tape 9:11 a.m. Today - Zacks.com
NeuroDerm (NDRM) in Focus: Stock Tanks 22.6% - Tale of the Tape 8:40 a.m. Jan. 2, 2015 - Zacks.com
NeuroDerm Skyrockets on Parkinson's Disease Study Data - Analyst Blog 3:50 p.m. Dec. 31, 2014 - Zacks.com
Market News: Civeo Corp, Eagle Rock Energy Partners, Neuderm Ltd 2:53 p.m. Dec. 31, 2014 - TheStreet.com
NeuroDerm (NDRM) Stock Plunges Today Following Tuesday's Gains 2:16 p.m. Dec. 31, 2014 - TheStreet.com
Today's Market: Stocks Making Solid Moves Into New Year 8:49 a.m. Dec. 31, 2014 - Seeking Alpha
Stocks Fall in Light Trading as Oil and Greece Weigh on Markets 4:09 p.m. Dec. 30, 2014 - TheStreet.com
Market News: Neuroderm Ltd, Civeo Corp, Expedia Inc 3:36 p.m. Dec. 30, 2014 - TheStreet.com
Neuroderm Shares Triple On Promising Parkinsons Drug Study 1:57 p.m. Dec. 30, 2014 - benzinga.com
NeuroDerm Is A Good Play In Parkinson's Disease 1:39 p.m. Dec. 30, 2014 - Seeking Alpha
NeuroDerm Rebounds On Parkinson's Disease Drug Data 11:19 a.m. Dec. 30, 2014 - Investors Business Daily
Why Goldcorp, Boyd Gaming, and Neuroderm are 3 of Today’s Best Stocks 11:10 a.m. Dec. 30, 2014 - InvestorPlace.com
NeuroDerm (NDRM) Stock Skyrockets to One-Year High After Encouraging Parkinson's Treatment Results 10:07 a.m. Dec. 30, 2014 - TheStreet.com
NeuroDerm LD/CD candidates deliver high levodopa levels in PD patients in study 8:25 a.m. Dec. 30, 2014 - Seeking Alpha
NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H And ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson's Disease 6:01 a.m. Dec. 30, 2014 - benzinga.com
First patient enrolled in Acorda Phase 3 PD trial 8:06 a.m. Dec. 10, 2014 - Seeking Alpha
Cynapsus Or Acorda - Whose Market Is It For Parkinson's Disease? 8:41 a.m. Nov. 25, 2014 - Seeking Alpha
This Week’s New Stocks: Will Habit Be the Next Hot Restaurant IPO? 11:53 a.m. Nov. 18, 2014 - InvestorPlace.com
IPO Preview: NeuroDerm 9:21 a.m. Nov. 14, 2014 - Seeking Alpha
The Beauty Of NeuroDerm's IPO Might Only Be Skin Deep 3:04 p.m. Nov. 13, 2014 - Seeking Alpha
Spot the Potential Winners: Research Reports on SEACOR, Shanda Games, Neuroderm, Seadrill, and Lockheed Martin 8:50 a.m. Dec. 31, 2014 - PR Newswire - PRF
NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson's Disease 7:01 a.m. Dec. 30, 2014 - GlobeNewswire
NeuroDerm Announces Third Quarter 2014 Financial Results and Provides a Corporate Update 7:01 a.m. Dec. 18, 2014 - GlobeNewswire
NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014 8:55 a.m. Dec. 5, 2014 - GlobeNewswire
NeuroDerm Announces Pricing of Initial Public Offering 12:29 a.m. Nov. 14, 2014 - GlobeNewswire
NeuroDerm Announces Launch of Initial Public Offering 7:21 a.m. Nov. 3, 2014 - PR Newswire - PRF
NeuroDerm Announces Presentation of ND0612L Top-line Phase II Results and ND0612H Preliminary Interim Phase IIa Results at the 2014 Parkinson's Disease Therapeutics Conference 6:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Civeo shares plunge; NeuroDerm jumps 11:51 a.m. Dec. 30, 2014 - Wallace Witkowski
NeuroDerm shares surge 19.6% as Parkinson's treatment shows promise 7:57 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm shares surge 18% in premarket trade 7:46 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm reports positive results in trial of Parkinson's treatment 7:45 a.m. Dec. 30, 2014 - Ciara Linnane
NeuroDerm Ltd. (NDRM) in Focus: Stock Surges 13.2% - Tale of the Tape 9:11 a.m. Today - Zacks.com
NeuroDerm (NDRM) in Focus: Stock Tanks 22.6% - Tale of the Tape 8:40 a.m. Jan. 2, 2015 - Zacks.com
NeuroDerm Skyrockets on Parkinson's Disease Study Data - Analyst Blog 3:50 p.m. Dec. 31, 2014 - Zacks.com
Market News: Civeo Corp, Eagle Rock Energy Partners, Neuderm Ltd 2:53 p.m. Dec. 31, 2014 - TheStreet.com
NeuroDerm (NDRM) Stock Plunges Today Following Tuesday's Gains 2:16 p.m. Dec. 31, 2014 - TheStreet.com
Today's Market: Stocks Making Solid Moves Into New Year 8:49 a.m. Dec. 31, 2014 - Seeking Alpha
Stocks Fall in Light Trading as Oil and Greece Weigh on Markets 4:09 p.m. Dec. 30, 2014 - TheStreet.com
Market News: Neuroderm Ltd, Civeo Corp, Expedia Inc 3:36 p.m. Dec. 30, 2014 - TheStreet.com
Neuroderm Shares Triple On Promising Parkinsons Drug Study 1:57 p.m. Dec. 30, 2014 - benzinga.com
NeuroDerm Is A Good Play In Parkinson's Disease 1:39 p.m. Dec. 30, 2014 - Seeking Alpha
NeuroDerm Rebounds On Parkinson's Disease Drug Data 11:19 a.m. Dec. 30, 2014 - Investors Business Daily
Why Goldcorp, Boyd Gaming, and Neuroderm are 3 of Today’s Best Stocks 11:10 a.m. Dec. 30, 2014 - InvestorPlace.com
NeuroDerm (NDRM) Stock Skyrockets to One-Year High After Encouraging Parkinson's Treatment Results 10:07 a.m. Dec. 30, 2014 - TheStreet.com
NeuroDerm LD/CD candidates deliver high levodopa levels in PD patients in study 8:25 a.m. Dec. 30, 2014 - Seeking Alpha
NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H And ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson's Disease 6:01 a.m. Dec. 30, 2014 - benzinga.com
First patient enrolled in Acorda Phase 3 PD trial 8:06 a.m. Dec. 10, 2014 - Seeking Alpha
Cynapsus Or Acorda - Whose Market Is It For Parkinson's Disease? 8:41 a.m. Nov. 25, 2014 - Seeking Alpha
This Week’s New Stocks: Will Habit Be the Next Hot Restaurant IPO? 11:53 a.m. Nov. 18, 2014 - InvestorPlace.com
IPO Preview: NeuroDerm 9:21 a.m. Nov. 14, 2014 - Seeking Alpha
The Beauty Of NeuroDerm's IPO Might Only Be Skin Deep 3:04 p.m. Nov. 13, 2014 - Seeking Alpha
Spot the Potential Winners: Research Reports on SEACOR, Shanda Games, Neuroderm, Seadrill, and Lockheed Martin 8:50 a.m. Dec. 31, 2014 - PR Newswire - PRF
NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson's Disease 7:01 a.m. Dec. 30, 2014 - GlobeNewswire
NeuroDerm Announces Third Quarter 2014 Financial Results and Provides a Corporate Update 7:01 a.m. Dec. 18, 2014 - GlobeNewswire
NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014 8:55 a.m. Dec. 5, 2014 - GlobeNewswire
NeuroDerm Announces Pricing of Initial Public Offering 12:29 a.m. Nov. 14, 2014 - GlobeNewswire
NeuroDerm Announces Launch of Initial Public Offering 7:21 a.m. Nov. 3, 2014 - PR Newswire - PRF
NeuroDerm Announces Presentation of ND0612L Top-line Phase II Results and ND0612H Preliminary Interim Phase IIa Results at the 2014 Parkinson's Disease Therapeutics Conference 6:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼